Nerve gas antidote completes phase I trial

June 9, 2010
Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …

Eisai’s breast cancer drug impresses at ASCO

June 9, 2010
Research and Development ASCO, Eisai, Xeloda, eribulin

A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …

Lansley calls for “cultural shift in the NHS”

June 9, 2010
NHS, government, king's fund

In his first speech as health secretary Andrew Lansley has called for a “cultural shift in the NHS”, moving away …

Tim Wragg to head up Millward Brown in Europe

June 9, 2010
Medical Communications Millward Brown, appointment, medical communications

Research company Millward Brown has appointed Tim Wragg to the newly-created position of chief executive, Europe. In his new position …

Dr Laurent Audoly joins Pieris

June 9, 2010
Research and Development Pieris, appointment, research and development

French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …

Talking Point: Crisis Management

June 9, 2010
Medical Communications Red Door, Talking Point

It is surprising to me how many companies and people in business are under-prepared and under-rehearsed for a crisis. On …

EMA sees fewer quality defects in ’09 inspections

June 9, 2010
Manufacturing and Production API, EMA, manufacturing, manufacturing compliance

The European Medicines Agency carried out 175 inspections of manufacturing facilities in 2009, a little lower than its target, according …

Eurocom expands international network

June 9, 2010
Medical Communications Eurocom, PBK

Eurocom Healthcare Communications has expanded its international communications network, adding leading Austrian agency PBK Ideennrerich to the fold. Eurocom said …

Merck Serono resubmits oral MS therapy to FDA

June 8, 2010
Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …

Sanofi to develop monoclonal antibody jabs

June 8, 2010
Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …

EU regulators to assess potential lupus breakthrough drug

June 8, 2010
Sales and Marketing Benlysta, Human Genome Sciences, Lupus

GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …

CME Spotlight: Power to the people

June 8, 2010
Medical Communications, Sales and Marketing CME Spotlight, transparency

The UK general election is now over and as we stayed up to watch the count, or woke on the …

EMA under fire for blocking data access

June 8, 2010
Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data

The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …

Novo ethics tools

Digital Pharma: Novo Nordisk’s online ethics tools

June 8, 2010
Medical Communications, Sales and Marketing Novo Nordisk, compliance, ethics

Two new e-learning tools have been launched to help shed some light on ethical grey areas and give individuals a …

Idis appoints Richard Greatorex

June 8, 2010
Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …

Manufacturing news in brief

June 8, 2010
Manufacturing and Production AHP Manufacturing, Caraco Pharmaceutical, Hospira, KV Pharmaceutical, Pharmalucence

The pharmaceutical manufacturing sector had another week of mixed fortunes, with yet more recalls being announced and a former Wyeth …

Chiltern Achieves Supplementary Accreditation from the Medicines & Healthcare Products Regulatory Agency

June 7, 2010
Research and Development

Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, “In November 2007, the MHRA launched a voluntary accreditation scheme for …

Pfizer launches UK pharmacy service

June 7, 2010
NHS, NHS Constitution, NHS Health Check, Pfizer

Pfizer has launched a new pharmacy-based service that will enable Primary Care Trusts in England to provide the NHS Health …

Nexium

AZ submits Nexium-aspirin combination for EU approval

June 7, 2010
Sales and Marketing AstraZeneca, Nexium, aspirin

AstraZeneca is seeking European approval for a new version of its anti-ulcer blockbuster Nexium that combines the pill with aspirin. …

Avastin packs

Avastin promising in ovarian cancer

June 7, 2010
Research and Development ASCO, avastin

Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …

The Gateway to Local Adoption Series

Latest content